CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-01-15 | Pavco Pamela VP of Pharmaceutical Devlpmt. | Grant or award · Stock Option | +47,000 | 234,137 | ||
| 2009-01-15 | GALLIKER STEPHEN S Director | Grant or award · Stock Option | +50,000 | 150,000 | ||
| 2009-01-15 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option | +50,000 | 150,000 | ||
| 2009-01-15 | Hillsberg Sanford Director | Grant or award · Stock Option | +50,000 | 150,000 | ||
| 2009-01-15 | Ahn Mark J Director | Grant or award · Stock Option | +50,000 | 150,000 | ||
| 2009-01-15 | Nisi Rudolph Director | Grant or award · Stock Option | +35,500 | 50,000 | ||
| 2008-10-17 | Khvorova Anastasia Chief Scientific Officer | Grant or award · Employee Stock Option | +151,652 | 190,000 | ||
| 2008-10-17 | Khvorova Anastasia Chief Scientific Officer | Grant or award · Employee Stock Option | +38,348 | 190,000 | ||
| 2008-04-18 | Woolf Tod President and CEO | Grant or award · Incentive Stock Option | +55,106 | 55,106 | ||
| 2008-04-18 | Samarsky Dmitry VP, Technology Development | Grant or award · Incentive Stock Option | +22,699 | 22,699 | ||
| 2008-04-18 | Pavco Pamela VP of Pharmaceutical Devlpmt. | Grant or award · Incentive Stock Option | +41,826 | 41,826 | ||
| 2008-04-18 | KRIEGSMAN STEVEN A Director | Grant or award · Non-Qualified Stock Option | +25,000 | 25,000 | ||
| 2008-04-18 | DiPalma Stephen J. CFO and Secretary | Grant or award · Incentive Stock Option | +19,428 | 19,428 | ||
| 2008-04-18 | Hillsberg Sanford Director | Grant or award · Non-Qualified Stock Option | +25,000 | 25,000 | ||
| 2008-04-18 | GALLIKER STEPHEN S Director | Grant or award · Non-Qualified Stock Option | +25,000 | 25,000 | ||
| 2008-04-18 | Ahn Mark J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2008-03-11 | KRIEGSMAN STEVEN A Director | Other acquisition | +8,990 | 8,990 | ||
| 2008-03-11 | KRIEGSMAN STEVEN A Director | Other acquisition | +200,594 | 209,584 | ||
| 2008-03-11 | CYTRX CORP 10% owner | Other disposition | −4,526,624 | 6,296,575 | ||
| 2008-03-11 | CYTRX CORP 10% owner | Other disposition | −27,694 | 6,268,881 |
Page 29 of 29 · 580 trades